Browsing: Health

DR Congo’s Ebola outbreak has surpassed 8,000 confirmed cases across seven provinces. The government officially announced the outbreak on May 15, attributing it to the Bundibugyo virus. It marks the Democratic Republic of the Congo’s 17th Ebola outbreak on record. The Bundibugyo virus is one of the Ebola virus species known to cause severe illness in humans. According to the World Health Organization, there is currently no licensed vaccine or approved treatment specifically targeting Bundibugyo virus disease. While Ituri remains the primary hotspot of the epidemic, infections have been reported in multiple other regions. These include the provinces of Ituri, North Kivu, South Kivu, Tshopo, Haut Uele, Bas Uele, and Sud Ubangi. Data from WHO indicated that by September 23, Ituri had reported cases in 28 of its 36 health zones, whereas North Kivu had cases in 16 of its 34 zones. Transmission rates decrease but remain significant in some areas Recent reports from the World Health Organization show a decline in new infections and fatalities. The organization noted a 20.3% drop in incident cases over the last two 14-day periods, with deaths decreasing by 24.2% during the same timeframe. Nonetheless, certain regions of Ituri continue to experience high transmission rates, with local trends worsening in some communities. By September 26, health teams had achieved 2,070 recoveries, as efforts in

Genetic Mutation Identified as Significant Risk Factor for Lung Cancer in Market Innovation WASHINGTON / RankWire.AI / – A groundbreaking study published in the journal Science has revealed a rare inherited genetic mutation that can elevate an individual’s risk of developing lung cancer by approximately 25 times overall and by about 60 times among non-smokers, according to researchers. This research, carried out by scientists at the Dana-Farber Cancer Institute in collaboration with the 23andMe Research Institute, utilized de-identified genetic information from over 3.3 million individuals. The germline variant known as EGFR T790M was identified by the team as one of the strongest inherited risk factors for lung cancer discovered to date.

India warns consumers about two Pakistan-made whitening creams linked to heavy metals. (AI-generated image) The agency stated that these cosmetics lack the necessary registration certificates from the competent authority for import into India. Under Indian regulations, imported cosmetics and their production facilities must be registered prior to market entry. The registration process is governed by the Cosmetics Rules, 2020, alongside the Drugs and Cosmetics Act, 1940. The Bureau of Indian Standards provides standards applicable to cosmetic products. The central notice, however, did not specify which heavy metals were present or detail their concentrations in each product. Consumers are advised not to buy Goree Beauty Cream or Chandni Whitening Cream, and those who already possess them should refrain from using these products. The alert extends to similar products with comparable names that may also lack proper authorization. Officials have instructed vendors, distributors, and advertisers to cease marketing these items. Enforcement agencies have been directed to prevent the sale of unauthorized cosmetics within their jurisdictions. Customers encountering labeling violations can report such products to the Drugs Controller General of India. Consumers should verify cosmetic labels carefully The safety alert emphasizes the importance of selecting cosmetics that display authorized labels containing essential regulatory and product details. These labels should include manufacturer information, a manufacturing license number, batch number, as well as manufacturing and expiry dates. For imported cosmetics, the registration number must also be visible. These label elements enable both consumers and authorities to verify whether a product is authorized for sale in India. The regulator’s advice centers on proper

According to the World Health Organization, there are signs of a decline in Ebola transmission within some of the most severely affected regions of the Democratic Republic of the Congo. The most notable improvements are observed in parts of Ituri province, which is the central hub of the outbreak. Nevertheless, the epidemic continues to spread in other locations. Data released up to Sept. 13 indicates a total of 7,258 confirmed cases and 3,510 deaths across seven provinces, with the country’s overall case fatality rate at 48.4%.

A cooling tower at Yankee Stadium tested positive for Legionella DNA in initial assessments, as authorities in New York City probe a cluster of Legionnaires’ disease cases in the South Bronx. By Tuesday night, the city confirmed 11 cases, which included one fatality, with three individuals still hospitalized. The New York City Health Department identified 10 cooling towers with preliminary positive PCR results across ZIP codes 10451 and 10456, covering sections of Melrose and Morrisania.

A severe lack of trained healthcare workers, operational partners, and financial backing is creating a critical bottleneck in efforts to contain the growing Ebola outbreak in the Democratic Republic of the Congo. As per technical briefings from the World Health Organization, the outbreak has extended beyond its initial focus in Bunia to involve six northeastern provinces. The current epidemic, caused by the Bundibugyo species of the virus, has recorded more than 6,000 cases and 3,175 deaths, making it the deadliest Ebola outbreak in the country’s history. International agencies highlight that staffing shortages and inadequate funding are hindering Ebola containment efforts, urging global donors to accelerate their financial support.

The World Health Organization has called for a major expansion of the Ebola response in the Democratic Republic of the Congo. Director-General Tedros Adhanom Ghebreyesus said health teams still have not identified every chain of transmission. Congo had recorded 6,250 confirmed cases and 3,039 deaths as of Sept. 1, according to the latest government figures. The Bundibugyo Ebola outbreak now affects 60 health zones across six provinces.

In Kisangani, the capital of Tshopo Province, health authorities in the Democratic Republic of the Congo have initiated a focused Ebola vaccination drive to fight the nation’s most severe outbreak to date. Frontline healthcare workers, emergency response teams, and individuals with direct exposure to confirmed cases are being prioritized during the initial phase of the deployment. Health Minister Roger Kamba announced that the government launched the immunization effort using doses of the Ervebo vaccine to protect frontline personnel working in the affected eastern regions.

EU diagnostic support expands as health authorities respond to the Bundibugyo Ebola outbreak. The PCR testing kits will be sent to the World Health Organization’s Hub for Global Health Emergencies Logistics located in Dubai. WHO will oversee their distribution to regions involved in the Ebola containment efforts. PCR diagnostics are vital for confirming infections, as laboratories can handle numerous samples with high precision. These devices are compatible with existing lab setups, allowing quicker confirmation of cases to facilitate patient treatment, isolation procedures, and contact tracing efforts. This procurement builds upon a prior European Commission agreement that allocated €2.5 million for rapid molecular point-of-care testing devices and related instruments. These supplies will be allocated to the Africa Centres for Disease Control and Prevention. Collectively, the two initiatives elevate the Commission’s recent diagnostic aid investments to €4.6 million. These actions form part of a broader European strategy to support the Ebola emergency in Bundibugyo, which continues to strain healthcare systems across parts of Central and East Africa. Diagnostic assistance grows as the outbreak intensifies By August 12, WHO reported that the Democratic Republic of the Congo had recorded 4,665 confirmed cases and 2,184 deaths. The outbreak affected 54 health zones spanning six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized this as the largest Ebola outbreak ever documented in the country. The agency also noted that transmission remains highly active, with

The Democratic Republic of the Congo has been allocated 70,000 Ervebo Ebola vaccine doses amidst the expanding outbreak in Bundibugyo. As of Aug. 18, Congolese health authorities reported 5,208 confirmed cases and 2,476 fatalities. The outbreak now spans 56 health zones within six provinces located in the east and northeast regions. Officials also noted 1,115 recoveries, while 730 patients remain under isolation or receiving hospital treatment.